Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Andrology

Free Subscription Articles published in J Urol Retrieve available abstracts of 187 articles: HTML format

Single Articles

December 2025
1. MCKIE KA, Moturu A, Graham DA, Coleman M, et al
   Antibiotic Prophylaxis Use and Outcomes in Children Undergoing Laparoscopic Orchiopexy.
   J Urol. 2025;214:622-630.
   PubMed     Abstract available
   
   
   November 2025
2. LIN YH, Chen JY, Chen CL
   Letter: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
   J Urol. 2025 Nov 20:101097JU0000000000004798. doi: 10.1097/JU.0000000000004798.
   PubMed    
   
   
   
3. BHAMBHVANI HP, Kuchakulla M, Poppas PJ, Greenberg DR, et al
   Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
   J Urol. 2025 Nov 20:101097JU0000000000004810. doi: 10.1097/JU.0000000000004810.
   PubMed    
   
   
   
4. MOUSA A, Chavarriaga J, Kaushal S, Burrafato Z, et al
   Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell Tumours.
   J Urol. 2025 Nov 10:101097JU0000000000004847. doi: 10.1097/JU.0000000000004847.
   PubMed     Abstract available
   
   
   October 2025
5. RITCH CR
   Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
   J Urol. 2025 Oct 29:101097JU0000000000004809. doi: 10.1097/JU.0000000000004809.
   PubMed    
   
   
   September 2025
6. DAVIS MF, Nikolavsky D, Cavalcanti AG, Flynn BJ, et al
   Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery Following Urethroplasty.
   J Urol. 2025 Sep 29:101097JU0000000000004794. doi: 10.1097/JU.0000000000004794.
   PubMed     Abstract available
   
   
   
7. KAPLAN SA
   Benign Prostatic Hyperplasia.
   J Urol. 2025 Sep 29:101097JU0000000000004775. doi: 10.1097/JU.0000000000004775.
   PubMed    
   
   
   
8. BHAMBHVANI HP, Kuchakulla M, Poppas P, Greenberg DR, et al
   Cross-Sectional Association of Time Spent Outdoors with Serum Testosterone: Results from NHANES.
   J Urol. 2025 Sep 19:101097JU0000000000004789. doi: 10.1097/JU.0000000000004789.
   PubMed     Abstract available
   
   
   
9. RITCH CR
   Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
   J Urol. 2025 Sep 11:101097JU0000000000004754. doi: 10.1097/JU.0000000000004754.
   PubMed    
   
   
   
10. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Sep 2:101097JU0000000000004710. doi: 10.1097/JU.0000000000004710.
    PubMed    
    
    
    
11. HU B, Alsyouf M, Farkouh A, Cary C, et al
    Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.
    J Urol. 2025;214:272-279.
    PubMed     Abstract available
    
    
    August 2025
12. VAVILOV S, Nolan E, Pockney P, Smith GH, et al
    Long-term risk of reoperation following hypospadias surgery in childhood: a data-linkage study.
    J Urol. 2025 Aug 12:101097JU0000000000004715. doi: 10.1097/JU.0000000000004715.
    PubMed     Abstract available
    
    
    
13. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.
    J Urol. 2025;214:116-126.
    PubMed     Abstract available
    
    
    
14. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    J Urol. 2025;214:127-137.
    PubMed     Abstract available
    
    
    July 2025
15. LIN YH, Chen JY, Wu CT
    A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2025 Jul 24:101097JU0000000000004692. doi: 10.1097/JU.0000000000004692.
    PubMed    
    
    
    
16. MATULEWICZ RS, Assel M, Vickers AJ, Jayalath VH, et al
    Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors.
    J Urol. 2025 Jul 7:101097JU0000000000004668. doi: 10.1097/JU.0000000000004668.
    PubMed    
    
    
    
17. LEWER O, Felice MD, Copelan O, Janakiraman S, et al
    Prostate Size and Its Effect on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Improvement After Convective Water Vapor Thermal Therapy.
    J Urol. 2025;214:48-57.
    PubMed     Abstract available
    
    
    
18. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Jul 1:101097JU0000000000004640. doi: 10.1097/JU.0000000000004640.
    PubMed    
    
    
    June 2025
19. ZENG J, McFadden J, Thakker P, Tachibana I, et al
    Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.
    J Urol. 2025;213:753-765.
    PubMed     Abstract available
    
    
    May 2025
20. DIETRICH P, Werner Z
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004609. doi: 10.1097/JU.0000000000004609.
    PubMed    
    
    
    
21. DMOCHOWSKI R
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004607. doi: 10.1097/JU.0000000000004607.
    PubMed    
    
    
    
22. JEFFERY J, Punjani N
    Editorial Comment on "A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy".
    J Urol. 2025 May 23:101097JU0000000000004608. doi: 10.1097/JU.0000000000004608.
    PubMed    
    
    
    April 2025
23. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Apr 29:101097JU0000000000004572. doi: 10.1097/JU.0000000000004572.
    PubMed    
    
    
    
24. COPLEN DE
    Editorial Comment: Re: Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results from NSQIP-Pediatric.
    J Urol. 2025 Apr 28:101097JU0000000000004575. doi: 10.1097/JU.0000000000004575.
    PubMed    
    
    
    
25. DOERSCH KM, Diamond DA
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 28:101097JU0000000000004574. doi: 10.1097/JU.0000000000004574.
    PubMed    
    
    
    
26. PEDERSEN TB, Secher C, Moumneh A, Hvid N, et al
    A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 Apr 28:101097JU0000000000004576. doi: 10.1097/JU.0000000000004576.
    PubMed     Abstract available
    
    
    
27. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.
    J Urol. 2025 Apr 17:101097JU0000000000004566. doi: 10.1097/JU.0000000000004566.
    PubMed     Abstract available
    
    
    
28. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Apr 8:101097JU0000000000004543. doi: 10.1097/JU.0000000000004543.
    PubMed    
    
    
    
29. BASIN MF, Gopalakrishnan M, Ackerman N, Mason MD, et al
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 3:101097JU0000000000004558. doi: 10.1097/JU.0000000000004558.
    PubMed     Abstract available
    
    
    March 2025
30. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Mar 27:101097JU0000000000004520. doi: 10.1097/JU.0000000000004520.
    PubMed    
    
    
    
31. NI X, Sui J, Wang B, Wang H, et al
    Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS.
    J Urol. 2025 Mar 25:101097JU0000000000004545. doi: 10.1097/JU.0000000000004545.
    PubMed     Abstract available
    
    
    February 2025
32. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 26:101097JU0000000000004479. doi: 10.1097/JU.0000000000004479.
    PubMed    
    
    
    
33. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 21:101097JU0000000000004389. doi: 10.1097/JU.0000000000004389.
    PubMed    
    
    
    
34. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Feb 17:101097JU0000000000004471. doi: 10.1097/JU.0000000000004471.
    PubMed    
    
    
    
35. PANDIT K, Morgan K, Riviere P, Dabbas M, et al
    Reply: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 12:101097JU0000000000004461. doi: 10.1097/JU.0000000000004461.
    PubMed    
    
    
    
36. HINOJOSA-GONZALEZ DE
    Letter: Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025 Feb 10:101097JU0000000000004454. doi: 10.1097/JU.0000000000004454.
    PubMed    
    
    
    
37. WANG W, Gao C, Fu K
    Letter: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 3:101097JU0000000000004440. doi: 10.1097/JU.0000000000004440.
    PubMed    
    
    
    
38. BENZOUAK T, Addar A, Prudencio-Brunello MA, Saed Aldien A, et al
    Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025;213:150-161.
    PubMed     Abstract available
    
    
    
39. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025;213:264-265.
    PubMed    
    
    
    January 2025
40. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Jan 23:101097JU0000000000004418. doi: 10.1097/JU.0000000000004418.
    PubMed    
    
    
    
41. HENGEL R, Vanni A, Erickson B, Elliott S, et al
    Multi-Institutional Analysis of Surgery for Lichen Sclerosus Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option.
    J Urol. 2025 Jan 21:101097JU0000000000004434. doi: 10.1097/JU.0000000000004434.
    PubMed     Abstract available
    
    
    
42. ABBASI B, Hacker E, Ghaffar U, Hakam N, et al
    Higher Morbidity and Mortality in Females With Fournier Gangrene Compared With Males: Insights From National Inpatient Sample Data.
    J Urol. 2025;213:99-109.
    PubMed     Abstract available
    
    
    December 2024
43. HA A, Zhang CA, Li S, Langroudi AP, et al
    A Contemporary Estimate of Vasectomy Failure in the United States: Analysis of US Claims Data.
    J Urol. 2024 Dec 31:101097JU0000000000004405. doi: 10.1097/JU.0000000000004405.
    PubMed     Abstract available
    
    
    
44. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Dec 11:101097JU0000000000004349. doi: 10.1097/JU.0000000000004349.
    PubMed    
    
    
    
45. ERICKSON BA, Tuong MN, Zorn AN, Schlaepfer CH, et al
    Development and Validation of the Length, Segment, and Etiology (LSE) Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data from the Trauma and Urologic Reconstruction Network of Surgeons.
    J Urol. 2024 Dec 9:101097JU0000000000004369. doi: 10.1097/JU.0000000000004369.
    PubMed     Abstract available
    
    
    
46. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Dec 9:101097JU0000000000004345. doi: 10.1097/JU.0000000000004345.
    PubMed    
    
    
    
47. LEUNBACH TL, Berglund A, Ernst A, Hvistendahl GM, et al
    Prevalence, Incidence, and Age at Diagnosis of Boys With Hypospadias: A Nationwide Population-Based Epidemiological Study.
    J Urol. 2024 Dec 3:101097JU0000000000004319. doi: 10.1097/JU.0000000000004319.
    PubMed     Abstract available
    
    
    
48. GREENBERG DR, Gago LC, Kumar SKSR, Panken EJ, et al
    Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation.
    J Urol. 2024;212:891-898.
    PubMed     Abstract available
    
    
    
49. BRANNIGAN RE, Hermanson L, Kaczmarek J, Kim SK, et al
    Updates to Male Infertility: AUA/ASRM Guideline (2024).
    J Urol. 2024;212:789-799.
    PubMed     Abstract available
    
    
    
50. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;212:924-926.
    PubMed    
    
    
    November 2024
51. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Nov 20:101097JU0000000000004320. doi: 10.1097/JU.0000000000004320.
    PubMed    
    
    
    
52. NESTLER T, Heidenreich A
    Letter: Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Nov 5:101097JU0000000000004304. doi: 10.1097/JU.0000000000004304.
    PubMed    
    
    
    
53. CHANG SS
    Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:779-780.
    PubMed    
    
    
    October 2024
54. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancers and Basic Principles of Oncology.
    J Urol. 2024 Oct 24:101097JU0000000000004288. doi: 10.1097/JU.0000000000004288.
    PubMed    
    
    
    
55. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
    Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial.
    J Urol. 2024 Oct 23:101097JU0000000000004291. doi: 10.1097/JU.0000000000004291.
    PubMed    
    
    
    
56. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Oct 8:101097JU0000000000004240. doi: 10.1097/JU.0000000000004240.
    PubMed    
    
    
    
57. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:633-635.
    PubMed    
    
    
    
58. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:639-640.
    PubMed    
    
    
    September 2024
59. FLORES JM, Vertosick EA, Salter CA, Benfante N, et al
    Testosterone Therapy in Men After Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer.
    J Urol. 2024 Sep 30:101097JU0000000000004267. doi: 10.1097/JU.0000000000004267.
    PubMed     Abstract available
    
    
    
60. PANDIT K, Riviere P, Morgan K, Nelson T, et al
    Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2024 Sep 30:101097JU0000000000004259. doi: 10.1097/JU.0000000000004259.
    PubMed     Abstract available
    
    
    
61. DIECKMANN KP, Belge G
    Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
    J Urol. 2024 Sep 17:101097JU0000000000004241. doi: 10.1097/JU.0000000000004241.
    PubMed    
    
    
    
62. ALSYOUF M, Ghoreifi A, Ashrafi A, Ladi-Seyedian SS, et al
    11-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Sep 13:101097JU0000000000004246. doi: 10.1097/JU.0000000000004246.
    PubMed     Abstract available
    
    
    
63. TROST L, Mulhall J, Hellstrom W
    Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria.
    J Urol. 2024;212:470-482.
    PubMed     Abstract available
    
    
    August 2024
64. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Aug 22:101097JU0000000000004206. doi: 10.1097/JU.0000000000004206.
    PubMed    
    
    
    
65. YU T, Yang Y, Shan D, Li J, et al
    Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 Aug 22:101097JU0000000000004200. doi: 10.1097/JU.0000000000004200.
    PubMed    
    
    
    
66. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Aug 20:101097JU0000000000004211. doi: 10.1097/JU.0000000000004211.
    PubMed    
    
    
    
67. GU C, Belarmino A, Kenfield SA, Nolte D, et al
    Post-Vasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit.
    J Urol. 2024 Aug 2:101097JU0000000000004185. doi: 10.1097/JU.0000000000004185.
    PubMed     Abstract available
    
    
    
68. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:386-388.
    PubMed    
    
    
    
69. PATEL HV, Li KD, Rourke K, Smith TG 3rd, et al
    The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty - A Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Analysis.
    J Urol. 2024 Aug 1:101097JU0000000000004188. doi: 10.1097/JU.0000000000004188.
    PubMed     Abstract available
    
    
    
70. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;212:381-384.
    PubMed    
    
    
    July 2024
71. ALSYOUF M, Daneshmand S
    Moving the Needle in Early Stage Testicular Germ Cell Tumor Management: The MAGESTIC Trial.
    J Urol. 2024 Jul 31:101097JU0000000000004182. doi: 10.1097/JU.0000000000004182.
    PubMed    
    
    
    
72. THOR A, Myklebust MP, Bergdahl AG, Lundgren PO, et al
    miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
    J Urol. 2024 Jul 25:101097JU0000000000004164. doi: 10.1097/JU.0000000000004164.
    PubMed     Abstract available
    
    
    
73. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jul 25:101097JU0000000000004153. doi: 10.1097/JU.0000000000004153.
    PubMed    
    
    
    
74. BATUR AF, Altintas E, Gul M
    Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 Jul 25:101097JU0000000000004156. doi: 10.1097/JU.0000000000004156.
    PubMed    
    
    
    
75. CHANG SS
    Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jul 25:101097JU0000000000004120. doi: 10.1097/JU.0000000000004120.
    PubMed    
    
    
    
76. LAZAROVICH A, Dahmen AS, Modi PK, Agarawal PK, et al
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:236-237.
    PubMed    
    
    
    
77. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:247-248.
    PubMed    
    
    
    
78. KAPLAN SA
    BPH.
    J Urol. 2024;212:241-243.
    PubMed    
    
    
    
79. HAYON S, Kumar SKS, Greenberg D, Mi X, et al
    Distribution and Positive Predictive Value of Follicle Stimulating Hormone Among Nonazoospermic Men.
    J Urol. 2024;212:145-152.
    PubMed     Abstract available
    
    
    
80. 
    Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial: Erratum.
    J Urol. 2024;212:249.
    PubMed    
    
    
    June 2024
81. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jun 17:101097JU0000000000004092. doi: 10.1097/JU.0000000000004092.
    PubMed    
    
    
    
82. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Jun 11:101097JU0000000000004083. doi: 10.1097/JU.0000000000004083.
    PubMed    
    
    
    
83. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:809-811.
    PubMed    
    
    
    
84. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:814-816.
    PubMed    
    
    
    
85. 
    Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management: Erratum.
    J Urol. 2024;211:820.
    PubMed    
    
    
    
86. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;211:811-813.
    PubMed    
    
    
    May 2024
87. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 May 24:101097JU0000000000003951. doi: 10.1097/JU.0000000000003951.
    PubMed    
    
    
    
88. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 May 17:101097JU0000000000004026. doi: 10.1097/JU.0000000000004026.
    PubMed    
    
    
    
89. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 May 17:101097JU0000000000004018. doi: 10.1097/JU.0000000000004018.
    PubMed    
    
    
    
90. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
    Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 May 6:101097JU0000000000003999. doi: 10.1097/JU.0000000000003999.
    PubMed     Abstract available
    
    
    
91. MOULI S, Salem R, McClure TD
    Prostate Artery Embolization for Benign Prostatic Hyperplasia.
    J Urol. 2024 May 4:101097JU0000000000003976. doi: 10.1097/JU.0000000000003976.
    PubMed    
    
    
    
92. TROST L
    Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2024;211:710-712.
    PubMed    
    
    
    
93. DESOUKY E, Levine LA
    Letter: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2024;211:708-709.
    PubMed    
    
    
    
94. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:722-723.
    PubMed    
    
    
    
95. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:720-721.
    PubMed    
    
    
    
96. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:720-721.
    PubMed    
    
    
    April 2024
97. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Apr 22:101097JU0000000000003900. doi: 10.1097/JU.0000000000003900.
    PubMed    
    
    
    
98. PINKHASOV AM, Viers BR
    Letter: Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
    J Urol. 2024 Apr 10:101097JU0000000000003939. doi: 10.1097/JU.0000000000003939.
    PubMed    
    
    
    
99. TROST L
    Update to the Testosterone Guideline.
    J Urol. 2024;211:608-610.
    PubMed    
    
    
    
100. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:631-633.
     PubMed    
     
     
     
101. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;211:630-631.
     PubMed    
     
     
     
102. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:638-639.
     PubMed    
     
     
     March 2024
103. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Mar 20:101097JU0000000000003872. doi: 10.1097/JU.0000000000003872.
     PubMed    
     
     
     
104. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Mar 15:101097JU0000000000003875. doi: 10.1097/JU.0000000000003875.
     PubMed    
     
     
     
105. BARKER ES, Chiu K, Brown VL, Morsy H, et al
     Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-Analysis of the Peer-Reviewed Flare Literature.
     J Urol. 2024;211:341-353.
     PubMed     Abstract available
     
     
     
106. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:489-490.
     PubMed    
     
     
     
107. NESTLER T, Paffenholz P, Pfister D, Schoch J, et al
     Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
     J Urol. 2024;211:426-435.
     PubMed     Abstract available
     
     
     
108. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:500-501.
     PubMed    
     
     
     
109. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;211:485-487.
     PubMed    
     
     
     February 2024
110. PUNJANI N, Marinaro JA, Kang C, Gal J, et al
     Gabapentin for Post-operative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial.
     J Urol. 2024 Feb 21:101097JU0000000000003884. doi: 10.1097/JU.0000000000003884.
     PubMed     Abstract available
     
     
     
111. NG L, Kocur OM, Xie P, Cheung S, et al
     Timing of Testicular Biopsy in Relation to Oocyte Retrieval and the Outcomes of Intracytoplasmic Sperm Injection.
     J Urol. 2024 Feb 20:101097JU0000000000003894. doi: 10.1097/JU.0000000000003894.
     PubMed     Abstract available
     
     
     
112. CHANG KC, Hung SF
     Letter: Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
     J Urol. 2024 Feb 13:101097JU0000000000003861. doi: 10.1097/JU.0000000000003861.
     PubMed    
     
     
     
113. DEEBEL N, Ramasamy R
     Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2024 Feb 7:101097JU0000000000003867. doi: 10.1097/JU.0000000000003867.
     PubMed    
     
     
     
114. KAPLAN-MARANS E, Khurgin J
     Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2024 Feb 7:101097JU0000000000003868. doi: 10.1097/JU.0000000000003868.
     PubMed    
     
     
     
115. GREENBERG DR, Panken EJ, Amarasekera C
     Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting.
     J Urol. 2024;211:313-316.
     PubMed    
     
     
     
116. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:334-335.
     PubMed    
     
     
     January 2024
117. STERLING J, Simhan J, Flynn BJ, Rusilko P, et al
     Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
     J Urol. 2024 Jan 26:101097JU0000000000003848. doi: 10.1097/JU.0000000000003848.
     PubMed     Abstract available
     
     
     
118. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Jan 19:101097JU0000000000003839. doi: 10.1097/JU.0000000000003839.
     PubMed    
     
     
     
119. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Jan 15:101097JU0000000000003807. doi: 10.1097/JU.0000000000003807.
     PubMed    
     
     
     
120. O'CONNELL KA, Thomas JL, Murad F, Zhou G, et al
     Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
     J Urol. 2024;211:90-100.
     PubMed     Abstract available
     
     
     
121. MATULEWICZ RS, Benfante N, Funt SA, Feldman DR, et al
     Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
     J Urol. 2024;211:80-89.
     PubMed     Abstract available
     
     
     December 2023
122. CALVO CI, Fender K, Hoy N, Rourke K, et al
     Affirming Long-Term Outcomes after Contemporary Urethroplasty: The Adverse Impact of Increasing Stricture Length, Lichen Sclerosus, Radiation and Infectious Strictures.
     J Urol. 2023 Dec 18:101097JU0000000000003826. doi: 10.1097/JU.0000000000003826.
     PubMed     Abstract available
     
     
     
123. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Dec 14:101097JU0000000000003806. doi: 10.1097/JU.0000000000003806.
     PubMed    
     
     
     
124. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Dec 8:101097JU0000000000003762. doi: 10.1097/JU.0000000000003762.
     PubMed    
     
     
     
125. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:917-918.
     PubMed    
     
     
     
126. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:915-917.
     PubMed    
     
     
     November 2023
127. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Nov 17:101097JU0000000000003784. doi: 10.1097/JU.0000000000003784.
     PubMed    
     
     
     
128. KOHN TP, Agrawal P, Ory J, Hare J, et al
     Rises in Hematocrit is Associated with an Increased Risk of Major Adverse Cardiac Events in Men Starting Testosterone Therapy - A Retrospective Cohort Claims Database Analysis.
     J Urol. 2023 Nov 10:101097JU0000000000003786. doi: 10.1097/JU.0000000000003786.
     PubMed     Abstract available
     
     
     
129. SESSINE MS, Radoiu CS, Qi J, Labardee C, et al
     Can MRI Help Inform Which Men with a History of Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
     J Urol. 2023 Nov 6:101097JU0000000000003775. doi: 10.1097/JU.0000000000003775.
     PubMed     Abstract available
     
     
     
130. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Reply.
     J Urol. 2023;210:734-735.
     PubMed    
     
     
     
131. GREEN B, Flores A, Warner J, Kohler T, et al
     Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
     J Urol. 2023;210:791-802.
     PubMed     Abstract available
     
     
     October 2023
132. DANIELS JP, Mirocha J, Adjei M, Moreira D, et al
     Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
     J Urol. 2023 Oct 24:101097JU0000000000003738. doi: 10.1097/JU.0000000000003738.
     PubMed     Abstract available
     
     
     
133. KANG C, Punjani N, Kashanian JA, Schlegel PN, et al
     Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2023 Oct 24:101097JU0000000000003737. doi: 10.1097/JU.0000000000003737.
     PubMed     Abstract available
     
     
     
134. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Oct 20:101097JU0000000000003731. doi: 10.1097/JU.0000000000003731.
     PubMed    
     
     
     
135. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Oct 18:101097JU0000000000003735. doi: 10.1097/JU.0000000000003735.
     PubMed    
     
     
     
136. CLENNON EK, Duty B, Seideman C
     Overutilization of Transfer for Testicular Torsion: An Opportunity for Multilevel Policy Intervention.
     J Urol. 2023 Oct 13:101097JU0000000000003750. doi: 10.1097/JU.0000000000003750.
     PubMed    
     
     
     
137. AYANGBESAN A, Koch GE, Dagostino C, Proctor JM, et al
     Qualitative Analysis of Patient Experiences Reaching Urethroplasty for Recurrent Urethral Stricture Disease.
     J Urol. 2023 Oct 4:101097JU0000000000003722. doi: 10.1097/JU.0000000000003722.
     PubMed     Abstract available
     
     
     
138. PARK SH, Wilson SK, Wen L
     Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis.
     J Urol. 2023;210:678-687.
     PubMed     Abstract available
     
     
     September 2023
139. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Sep 25:101097JU0000000000003719. doi: 10.1097/JU.0000000000003719.
     PubMed    
     
     
     
140. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Sep 25:101097JU0000000000003714. doi: 10.1097/JU.0000000000003714.
     PubMed    
     
     
     
141. STEPHENSON A, Bass EB, Bixler BR, Daneshmand S, et al
     Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023.
     J Urol. 2023 Sep 14:101097JU0000000000003694. doi: 10.1097/JU.0000000000003694.
     PubMed     Abstract available
     
     
     
142. SANDHU JS, Bixler BR, Dahm P, Goueli R, et al
     Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.
     J Urol. 2023 Sep 14:101097JU0000000000003698. doi: 10.1097/JU.0000000000003698.
     PubMed     Abstract available
     
     
     
143. KALYVIANAKIS D, Poulios E, Mykoniatis I, Pyrgidis N, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter.
     J Urol. 2023 Sep 6:101097JU0000000000003684. doi: 10.1097/JU.0000000000003684.
     PubMed    
     
     
     
144. KAPLAN SA, Moss J, Freedman S, Coutinho K, et al
     The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
     J Urol. 2023;210:500-509.
     PubMed     Abstract available
     
     
     
145. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:553-555.
     PubMed    
     
     
     
146. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:555-556.
     PubMed    
     
     
     
147. FRENDL DM, Chou WH, Chen YW, Chang DC, et al
     Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference?
     J Urol. 2023;210:492-499.
     PubMed     Abstract available
     
     
     
148. RAGUE JT, Hirsch J, Meyer T, Streur C, et al
     "I Just Haven't Done Any of That": Applicability of the International Index of Erectile Function in Young Men With Spina Bifida.
     J Urol. 2023;210:538-547.
     PubMed     Abstract available
     
     
     August 2023
149. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Aug 24:101097JU0000000000003660. doi: 10.1097/JU.0000000000003660.
     PubMed    
     
     
     
150. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Aug 23:101097JU0000000000003665. doi: 10.1097/JU.0000000000003665.
     PubMed    
     
     
     
151. STANIORSKI CJ, Myrga JM, Vasan RV, Klein RD, et al
     Surgical outcomes and prediction of complications following high complexity buried penis reconstruction.
     J Urol. 2023 Aug 16:101097JU0000000000003669. doi: 10.1097/JU.0000000000003669.
     PubMed     Abstract available
     
     
     
152. KAPLAN-MARANS E, Marans H
     Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality. Letter.
     J Urol. 2023;210:251-252.
     PubMed    
     
     
     
153. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:368-370.
     PubMed    
     
     
     
154. DI H, Wen Y
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
     J Urol. 2023 Aug 1:101097JU0000000000003636. doi: 10.1097/JU.0000000000003636.
     PubMed    
     
     
     
155. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Aug 1:101097JU0000000000003630. doi: 10.1097/JU.0000000000003630.
     PubMed    
     
     
     July 2023
156. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Jul 25:101097JU0000000000003622. doi: 10.1097/JU.0000000000003622.
     PubMed    
     
     
     
157. GODLEWSKI K, Mittal S, Long C
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Reply.
     J Urol. 2023 Jul 14:101097JU0000000000003608. doi: 10.1097/JU.0000000000003608.
     PubMed    
     
     
     
158. MOSA H
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
     J Urol. 2023 Jul 6:101097JU0000000000003607. doi: 10.1097/JU.0000000000003607.
     PubMed    
     
     
     
159. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:206-207.
     PubMed    
     
     
     
160. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:204-206.
     PubMed    
     
     
     June 2023
161. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Jun 19:101097JU0000000000003577. doi: 10.1097/JU.0000000000003577.
     PubMed    
     
     
     
162. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 Jun 19:101097JU0000000000003588. doi: 10.1097/JU.0000000000003588.
     PubMed    
     
     
     
163. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Jun 15:101097JU0000000000003580. doi: 10.1097/JU.0000000000003580.
     PubMed    
     
     
     
164. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:1218-1221.
     PubMed    
     
     
     
165. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;209:1216-1218.
     PubMed    
     
     
     
166. STEPHENS-SHIELDS AJ, Lai HH, Landis JR, Kreder K, et al
     Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.
     J Urol. 2023;209:1132-1140.
     PubMed     Abstract available
     
     
     May 2023
167. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 May 18:101097JU0000000000003542. doi: 10.1097/JU.0000000000003542.
     PubMed    
     
     
     
168. GODLEWSKI KF, Mittal S, Hyacinthe N, Fischer K, et al
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair with Urethroplasty?
     J Urol. 2023 May 17:101097JU0000000000003548. doi: 10.1097/JU.0000000000003548.
     PubMed     Abstract available
     
     
     
169. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 May 17:101097JU0000000000003540. doi: 10.1097/JU.0000000000003540.
     PubMed    
     
     
     
170. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 May 9:101097JU0000000000003522. doi: 10.1097/JU.0000000000003522.
     PubMed    
     
     
     
171. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 May 2:101097JU0000000000003474. doi: 10.1097/JU.0000000000003474.
     PubMed    
     
     
     
172. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:1013-1014.
     PubMed    
     
     
     
173. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023;209:1028-1029.
     PubMed    
     
     
     
174. DAVARO F, Spiess PE
     Enlisting Urologists to Improve Palliative Care Services Integration in the Care of Advanced Penile Cancer.
     J Urol. 2023;209:824-826.
     PubMed    
     
     
     
175. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023;209:1025-1026.
     PubMed    
     
     
     
176. RIVERO MJ, Ory J, Diaz P, Thirumavalavan N, et al
     Comparison of Hematocrit Change in Testosterone-Deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
     J Urol. 2023 May 1:101097JU0000000000003487. doi: 10.1097/JU.0000000000003487.
     PubMed     Abstract available
     
     
     April 2023
177. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial.
     J Urol. 2023 Apr 30:101097JU0000000000003481. doi: 10.1097/JU.0000000000003481.
     PubMed     Abstract available
     
     
     
178. BHOJANI N, Bidair M, Kramolowsky E, Desai M, et al
     Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
     J Urol. 2023 Apr 28:101097JU0000000000003483. doi: 10.1097/JU.0000000000003483.
     PubMed     Abstract available
     
     
     
179. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Apr 27:101097JU0000000000003465. doi: 10.1097/JU.0000000000003465.
     PubMed    
     
     
     
180. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Apr 20:101097JU0000000000003470. doi: 10.1097/JU.0000000000003470.
     PubMed    
     
     
     
181. TUTOLO M, Briganti A, Salonia A, Montorsi F, et al
     Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
     J Urol. 2023 Apr 13:101097JU0000000000003484. doi: 10.1097/JU.0000000000003484.
     PubMed    
     
     
     
182. LENFANT L, Pinar U, Roupret M, Mozer P, et al
     RE: RE: Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
     J Urol. 2023 Apr 13:101097JU0000000000003485. doi: 10.1097/JU.0000000000003485.
     PubMed    
     
     
     
183. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:795-797.
     PubMed    
     
     
     
184. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;209:793-794.
     PubMed    
     
     
     March 2023
185. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 Mar 23:101097JU0000000000003419. doi: 10.1097/JU.0000000000003419.
     PubMed    
     
     
     
186. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Mar 23:101097JU0000000000003415. doi: 10.1097/JU.0000000000003415.
     PubMed    
     
     
     
187. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Mar 23:101097JU0000000000003411. doi: 10.1097/JU.0000000000003411.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge.